Sep 15, 2021 / 04:50PM GMT
Jeffrey D. Johnson - Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst
All right. I think we're all here. Good morning, good afternoon, I guess, it's one or the other, depending on where you are, but I think we'll get started. My name is Jeff Johnson. I'm the senior medical technology analyst at Baird. And our next presentation this morning or this afternoon is from Tandem Diabetes, a leader in the $3 billion global insulin pump market.
With us today from Tandem, we're happy to have Chief Financial Officer, Leigh Vosseller; and EVP and Chief Administrative Officer, Susan Morrison. Leigh, I'll turn it over to you if you have a few minutes of prepared remarks you'd like to make, and then we'll go straight into Q&A.
Leigh A. Vosseller - Tandem Diabetes Care, Inc. - Executive VP, CFO & Treasurer
Sure. So thanks for having us here today, Jeff. We're very happy to be here to talk with everyone. And one thing I'll just start out by saying it's been quite a wild ride at Tandem over the course of time since we first
Tandem Diabetes Care Inc at Robert W Baird Global Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
